Novel proteoforms with single amino acid variations represent proteins that often have altered biological functions but are less explored in the human proteome. We have developed an approach, searching high quality shotgun proteomic data against an extended protein database, to identify expressed mutant proteoforms in glioma stem cell (GSC) lines. The systematic search of MS/MS spectra using PEAKS 7.0 as the search engine has recognized 17 chromosome 19 proteins in GSCs with altered amino acid sequences. The results were further verified by manual spectral examination, validating 19 proteoforms. One of the novel findings, a mutant form of branched-chain aminotransferase 2 (<i>p.Thr186Arg</i>), was verified at the transcript level and by tar...
Glioblastoma (GBM) cancer stem cells (GSCs) contribute to GBM's origin, recurrence, and resistance t...
Primary brain tumors are predominantly malignant gliomas. Grade IV astrocytomas (glioblastomas, GBM)...
The goal of the Chromosome-Centric Human Proteome Project (C-HPP) is to fully provide proteomic info...
Novel proteoforms with single amino acid variations represent proteins that often have altered biolo...
*S Supporting Information ABSTRACT: Novel proteoforms with single amino acid variations represent pr...
Glioblastoma (GBM), the most malignant of primary brain tumors, is a devastating and deadly disease,...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
The 2016 WHO Classification of Tumors of the Central Nervous System separates IDH-mutant gliomas int...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
Structural technologies are an essential component in the design of precision therapeutics. Precisio...
Dynamic changes in the expression of multiple genes appear to be common features that distinguish tr...
International audiencePrimary cell lines derived as neurospheres, enriched in cancer stem cells, are...
BackgroundOnco-proteogenomics aims to understand how changes in a cancer's genome influences its pro...
Loss of p53 function is a common event in a variety of human cancers including tumors of glial origi...
Abstract Background Onco-proteogenomics aims to under...
Glioblastoma (GBM) cancer stem cells (GSCs) contribute to GBM's origin, recurrence, and resistance t...
Primary brain tumors are predominantly malignant gliomas. Grade IV astrocytomas (glioblastomas, GBM)...
The goal of the Chromosome-Centric Human Proteome Project (C-HPP) is to fully provide proteomic info...
Novel proteoforms with single amino acid variations represent proteins that often have altered biolo...
*S Supporting Information ABSTRACT: Novel proteoforms with single amino acid variations represent pr...
Glioblastoma (GBM), the most malignant of primary brain tumors, is a devastating and deadly disease,...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
The 2016 WHO Classification of Tumors of the Central Nervous System separates IDH-mutant gliomas int...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
Structural technologies are an essential component in the design of precision therapeutics. Precisio...
Dynamic changes in the expression of multiple genes appear to be common features that distinguish tr...
International audiencePrimary cell lines derived as neurospheres, enriched in cancer stem cells, are...
BackgroundOnco-proteogenomics aims to understand how changes in a cancer's genome influences its pro...
Loss of p53 function is a common event in a variety of human cancers including tumors of glial origi...
Abstract Background Onco-proteogenomics aims to under...
Glioblastoma (GBM) cancer stem cells (GSCs) contribute to GBM's origin, recurrence, and resistance t...
Primary brain tumors are predominantly malignant gliomas. Grade IV astrocytomas (glioblastomas, GBM)...
The goal of the Chromosome-Centric Human Proteome Project (C-HPP) is to fully provide proteomic info...